Longevity AI key facts
as of Oct 2026- Developer of a preventive healthcare platform designed to offer early diagnosis and intervention of major age-related diseases.
- Longevity AI is valued at approximately $13.0M as of Oct 2026 (last reported valuation).
- It has raised $5.2M; the latest was Early Stage VC ($4.5M) in May 2025.
- Notable investors include Kli Capital, Welltech Ventures.
- Status: Privately Held (backing).
Longevity AI's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch Longevity AI: the Monday email on marks, rounds and moves
Longevity AI funding rounds
No funding rounds for Longevity AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Longevity AI
2Longevity AI valuation
Longevity AI's last reported valuation was $13 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Longevity AI investors
2 investors are on record for Longevity AI, including Kli Capital and Welltech Ventures.
About Longevity AI
Developer of a preventive healthcare platform designed to offer early diagnosis and intervention of major age-related diseases. The company's platform utilizes artificial intelligence to offer a clinical dashboard for an understanding of patients, makes risk predictions based on the latest scientific discoveries, evidence-based medicine, and health information, provides health reports after every visit, and offers insights into habits and preferences, along with smart monitoring, enabling health providers to treat patients efficiently and improve the experience.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 32
- Website
- longevity-ai.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.